Unilever Indonesia Tbk PT
IDX:UNVR
Unilever Indonesia Tbk PT
IDX:UNVR
Price:
1 765
IDR
-2.22%
Market Closed
Market Cap:
67.3T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
UNVR Alert
Unilever Indonesia Tbk PT
1765
-40 (-2.22%)
| 52 Week Range |
1 735
3 560
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Unilever Indonesia Tbk PT
Balance Sheet
Balance Sheet Decomposition
Unilever Indonesia Tbk PT
Unilever Indonesia Tbk PT
| Current Assets | 5.7T |
| Cash & Short-Term Investments | 539.6B |
| Receivables | 2.6T |
| Other Current Assets | 2.6T |
| Non-Current Assets | 10.8T |
| PP&E | 9.8T |
| Intangibles | 412.4B |
| Other Non-Current Assets | 601.6B |
| Current Liabilities | 11.1T |
| Accounts Payable | 3.8T |
| Accrued Liabilities | 4.4T |
| Short-Term Debt | 400B |
| Other Current Liabilities | 2.5T |
| Non-Current Liabilities | 2T |
| Long-Term Debt | 487.3B |
| Other Non-Current Liabilities | 1.5T |
Balance Sheet
Unilever Indonesia Tbk PT
Unilever Indonesia Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
341 127
|
533 159
|
373 835
|
404 784
|
226 667
|
628 649
|
0
|
0
|
39 323
|
1 020 598
|
|
| Cash |
341 127
|
533 159
|
373 835
|
0
|
226 667
|
628 649
|
0
|
0
|
0
|
1 020 598
|
|
| Cash Equivalents |
0
|
0
|
0
|
404 784
|
0
|
0
|
0
|
0
|
39 323
|
0
|
|
| Short-Term Investments |
518 000
|
95 000
|
0
|
0
|
125 000
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
3 809 854
|
4 854 825
|
5 103 406
|
5 447 751
|
5 413 354
|
4 682 036
|
4 210 810
|
2 597 650
|
|
| Accounts Receivables |
0
|
0
|
3 708 257
|
4 715 554
|
4 983 471
|
5 335 489
|
5 295 288
|
4 516 555
|
3 924 499
|
2 343 012
|
|
| Other Receivables |
0
|
0
|
101 597
|
139 271
|
119 935
|
112 262
|
118 066
|
165 481
|
286 311
|
254 638
|
|
| Inventory |
0
|
0
|
2 318 130
|
2 393 540
|
2 658 073
|
2 429 234
|
2 463 104
|
2 453 871
|
2 625 116
|
2 422 044
|
|
| Other Current Assets |
0
|
0
|
86 290
|
223 237
|
144 764
|
24 700
|
107 826
|
181 104
|
228 960
|
151 547
|
|
| Total Current Assets |
0
|
0
|
6 588 109
|
7 876 386
|
8 257 910
|
8 530 334
|
8 828 360
|
7 642 208
|
7 567 768
|
6 191 839
|
|
| PP&E Net |
0
|
0
|
9 529 476
|
11 447 623
|
11 523 601
|
11 610 177
|
11 187 039
|
10 821 282
|
10 163 075
|
9 926 795
|
|
| PP&E Gross |
0
|
0
|
9 529 476
|
0
|
11 523 601
|
11 610 177
|
11 187 039
|
10 821 282
|
10 163 075
|
9 926 795
|
|
| Accumulated Depreciation |
2 000 687
|
2 373 102
|
2 870 710
|
0
|
3 944 516
|
4 571 032
|
5 254 870
|
6 013 019
|
6 364 762
|
6 768 317
|
|
| Intangible Assets |
0
|
0
|
409 802
|
390 838
|
434 205
|
402 718
|
408 242
|
474 825
|
447 059
|
399 468
|
|
| Goodwill |
0
|
0
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
|
| Other Long-Term Assets |
0
|
0
|
156 383
|
75 018
|
49 228
|
44 217
|
49 066
|
68 292
|
78 287
|
84 059
|
|
| Other Assets |
0
|
0
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
61 925
|
|
| Total Assets |
0
N/A
|
0
N/A
|
16 745 695
N/A
|
19 851 790
+19%
|
20 326 869
+2%
|
20 649 371
+2%
|
20 534 632
-1%
|
19 068 532
-7%
|
18 318 114
-4%
|
16 664 086
-9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
4 641 910
|
4 527 110
|
4 572 600
|
4 516 954
|
4 277 617
|
4 571 352
|
4 699 974
|
4 063 637
|
|
| Accrued Liabilities |
0
|
0
|
1 804 404
|
2 435 521
|
2 979 180
|
2 825 390
|
2 447 088
|
2 754 059
|
4 142 768
|
4 044 566
|
|
| Short-Term Debt |
0
|
0
|
2 392 970
|
3 450 000
|
460 000
|
2 920 000
|
3 015 000
|
1 850 000
|
600 000
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
166 310
|
139 036
|
126 179
|
113 186
|
83 249
|
35 621
|
209 526
|
|
| Other Current Liabilities |
0
|
0
|
2 038 790
|
2 119 673
|
3 123 006
|
2 676 785
|
3 504 645
|
3 186 492
|
2 963 860
|
2 906 239
|
|
| Total Current Liabilities |
0
|
0
|
10 878 074
|
12 698 614
|
11 273 822
|
13 065 308
|
13 357 536
|
12 445 152
|
12 442 223
|
11 223 968
|
|
| Long-Term Debt |
0
|
0
|
0
|
973 973
|
897 446
|
918 815
|
846 804
|
803 617
|
648 405
|
541 257
|
|
| Deferred Income Tax |
0
|
0
|
245 152
|
316 267
|
362 980
|
335 570
|
212 333
|
258 638
|
253 601
|
165 609
|
|
| Minority Interest |
56 769
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
918 211
|
855 756
|
412 004
|
1 047 816
|
1 180 591
|
1 239 856
|
976 629
|
1 352 014
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
12 041 437
N/A
|
14 844 610
+23%
|
12 946 252
-13%
|
15 367 509
+19%
|
15 597 264
+1%
|
14 747 263
-5%
|
14 320 858
-3%
|
13 282 848
-7%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
76 300
|
76 300
|
76 300
|
76 300
|
76 300
|
76 300
|
76 300
|
76 300
|
|
| Retained Earnings |
0
|
0
|
4 531 958
|
4 834 880
|
7 208 317
|
5 109 562
|
4 765 068
|
4 148 969
|
3 824 956
|
3 208 938
|
|
| Additional Paid In Capital |
0
|
0
|
96 000
|
96 000
|
96 000
|
96 000
|
96 000
|
96 000
|
96 000
|
96 000
|
|
| Total Equity |
0
N/A
|
0
N/A
|
4 704 258
N/A
|
5 007 180
+6%
|
7 380 617
+47%
|
5 281 862
-28%
|
4 937 368
-7%
|
4 321 269
-12%
|
3 997 256
-7%
|
3 381 238
-15%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
16 745 695
N/A
|
19 851 790
+19%
|
20 326 869
+2%
|
20 649 371
+2%
|
20 534 632
-1%
|
19 068 532
-7%
|
18 318 114
-4%
|
16 664 086
-9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
38 150
|
38 150
|
38 150
|
38 150
|
38 150
|
38 150
|
38 150
|
38 150
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
